Women with cancer in pregnancy planning delivery should be counseled that there is a higher risk of CS and postpartum hemorrhage
Delivery should be planned for 3 or more weeks after stopping 3‐weekly chemotherapy to enable recovery from maternal and fetal myelosuppression. Shorter interval (weekly) chemotherapy may need a 7–10‐day washout period
Vaginal birth is recommended unless contraindicated
Termination of pregnancy in the first or second trimester is a woman‐centered, MDT, and ethical decision and may be considered in advanced cancer, where treatment options safe in pregnancy are not the right choice for maternal benefit, upon maternal request, or where end‐of‐life care is being considered
Continuous monitoring during labor is recommended, with a low threshold for initiating antibiotics at the first sign of infection
The infant should be assessed by a neonatal team for infection, toxicity from chemotherapy, and for the presence of metastases where placental metastases have been identified
End‐of‐life care should consider the mother and newborn's bonding time, which should not be withheld
|